Cargando…
Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
A combination therapy of multiple drugs including isoniazid, rifampicin, ethambutol and pyrazinamide has been proven to be an effective option for the vast majority of tuberculosis (TB) patients. However, various adverse drug reactions (ADRs) limit its merit, with anti-TB drug-induced hepatotoxicity...
Autores principales: | Wang, Yu, Xiang, Xi, Huang, Wei-Wei, Sandford, Andrew J, Wu, Shou-Quan, Zhang, Miao-Miao, Wang, Ming-Gui, Chen, Guo, He, Jian-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379441/ https://www.ncbi.nlm.nih.gov/pubmed/30778091 http://dx.doi.org/10.1038/s41598-018-38452-z |
Ejemplares similares
-
Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment
por: Wang, Jann Yuan, et al.
Publicado: (2015) -
Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011) -
Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
por: Sharma, Surendra K., et al.
Publicado: (2016) -
Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011) -
Polymorphisms in Toll-Like Receptor 10 and Tuberculosis Susceptibility: Evidence from Three Independent Series
por: Wang, Yu, et al.
Publicado: (2018)